Head office

3F #307, 288, Digital-ro, Guro-gu,

Seoul, 08390, Republic of Korea

R&D center

3F #304~307, #314, 288, Digital-ro,

Guro-gu, Seoul, 08390, Republic of Korea

Email

business@ngenebio.com

Tel

02-867-9798

Fax

02-866-9784

NGeneBio

NGeneBio

NGeneBio advances precision diagnostics
by integrating genomic, real-world clinical, and pathological data through AI,
toward a global precision medicine data platform.

SCROLL

Our Origins

Pioneering Large-Scale Genomic Analysis in Korea

NGeneBio began as an internal venture at KT, developing Korea’s first large-scale genomic analysis platform in 2012.
The company was founded in 2015 to advance precision diagnostics, with a focus on cancer genomics.

Advancing the Global Precision Medicine Market

With the development of BRCAaccuTest, NGeneBio achieved Korea’s first MFDS approval and Asia’s first CE-IVD certification in genomic diagnostics, marking its entry into the global precision medicine market.

NGeneBio is currently
engaged in the following business areas.

  1. 01
    Diagnostics Products & Analysis Software

    Commercialized cancer genomic diagnostics, including BRCA and solid/hematologic tumor panels, supplied to major hospitals

    Development of companion diagnostics for anticancer drug prescription with hospitals and pharmaceutical partners

    Proven outcomes in liquid biopsy–based MRD diagnostics and genomic analysis platforms for biomarker discovery

  2. 02
    Medical Data Integration & AI Models

    Co-development of NGLIS(Next-generation Genomic Laboratory Information System) with ASAN Medical Center, integrating hospital EMR and genomic data

    Deployment across major university hospitals in Korea

    Integration of EGFR mutation detection AI (EXAONE Path 2.0) from LG AI Research into NGLIS for lung cancer diagnostics

    Ongoing development of AI models for variant interpretation and treatment response prediction

VISION

Global Precision Medicine
Innovator

MISSION

To integrate life sciences,
healthcare, and information technology
to develop innovative medical technologies
and make advanced healthcare services
accessible to all.

CORE VALUE

CORE
VALUE
  • Bold Execution

  • Respect for Life

  • Customer Trust

  • Talent Development

CI

The Innovative & Next Generation Biotechnology

CI Download
RED

C11 M98 Y96 K0

R229 G7 B25

RED-COLORED

C78 M82 Y83 K67

R35 G24 B21

BLACK

C93 M88 Y89 K80

R0 G0 B0